Adele P Williams - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Translational Oncology|July 31, 2019

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.

Cancers|July 2, 2021

Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell LinesLaura V Bownes, Adele P Williams, Raoud Marayati, et al.

Oncotarget|October 1, 2019

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumorJamie M Aye, Laura L Stafman, Adele P Williams, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Translational Oncology|July 31, 2019

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line XenograftsAdele P Williams, Evan F Garner, Laura L Stafman, et al.

Cancers|July 2, 2021

Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell LinesLaura V Bownes, Adele P Williams, Raoud Marayati, et al.

Oncotarget|October 1, 2019

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumorJamie M Aye, Laura L Stafman, Adele P Williams, et al.

Pageof 3